Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeliki Siamidi

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Pharmaceutics|March 28, 2024
In Vitro Profile of Hydrocortisone Release from Three-Dimensionally Printed Paediatric Mini-TabletsChrystalla Protopapa, Angeliki Siamidi, Siva Satyanarayana Kolipaka, et al.
International Journal of Molecular Sciences|August 10, 2017
Comparative In Vitro Controlled Release Studies on the Chronobiotic Hormone Melatonin from Cyclodextrins-Containing Matrices and Cyclodextrin: Melatonin ComplexesMarilena Vlachou, Marianna Papamichael, Angeliki Siamidi, et al.
Materials (Basel, Switzerland)|July 14, 2023
Design and Development of Low- and Medium-Viscosity Alginate Beads Loaded with Pluronic<sup>®</sup> F-127 NanomicellesFlora Kalogeropoulou, Dimitra Papailiou, Chrystalla Protopapa, et al.
Current Drug Delivery|September 15, 2018
Fabrication and Characterization of Electrospun Nanofibers for the Modified Release of the Chronobiotic Hormone MelatoninMarilena Vlachou, Stefanos Kikionis, Angeliki Siamidi, et al.
International Journal of Pharmaceutics|August 18, 2024
Sustained release of 3D printed bupropion hydrochloride tablets bearing Braille imprints for the visually impairedChrystalla Protopapa, Angeliki Siamidi, Laura Andrade Junqueira, et al.
Current Pharmaceutical Design|April 15, 2024
<i>In vitro</i> Modified Release Studies on Melatoninergic Fluorinated Phenylalkylamides: Circumventing their Lipophilicity for Oral AdministrationMarilena Vlachou, Angeliki Siamidi, Chrystalla Protopapa, et al.
Acta Pharmaceutica (Zagreb, Croatia)|May 16, 2020
Probing the release of the chronobiotic hormone melatonin from hybrid calcium alginate hydrogel beadsMarilena Vlachou, Angeliki Siamidi, Efstratia Goula, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
3D-Printed Melatonin Tablets with Braille Motifs for the Visually ImpairedChrystalla Protopapa, Angeliki Siamidi, Aikaterini Sakellaropoulou, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Biophysical Evaluation and In Vitro Controlled Release of Two Isomeric Adamantane Phenylalkylamines with Antiproliferative/Anticancer and Analgesic ActivityMarilena Vlachou, Angeliki-Sofia Foscolos, Angeliki Siamidi, et al.
Drug Research|July 21, 2017
In vitro Controlled Release of two new Tuberculocidal Adamantane Aminoethers from Solid Pharmaceutical Formulations (II)Marilena Vlachou, Angeliki Siamidi, Dimitrios Spaneas, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Pharmaceutics|March 28, 2024
In Vitro Profile of Hydrocortisone Release from Three-Dimensionally Printed Paediatric Mini-TabletsChrystalla Protopapa, Angeliki Siamidi, Siva Satyanarayana Kolipaka, et al.
International Journal of Molecular Sciences|August 10, 2017
Comparative In Vitro Controlled Release Studies on the Chronobiotic Hormone Melatonin from Cyclodextrins-Containing Matrices and Cyclodextrin: Melatonin ComplexesMarilena Vlachou, Marianna Papamichael, Angeliki Siamidi, et al.
Materials (Basel, Switzerland)|July 14, 2023
Design and Development of Low- and Medium-Viscosity Alginate Beads Loaded with Pluronic<sup>®</sup> F-127 NanomicellesFlora Kalogeropoulou, Dimitra Papailiou, Chrystalla Protopapa, et al.
Current Drug Delivery|September 15, 2018
Fabrication and Characterization of Electrospun Nanofibers for the Modified Release of the Chronobiotic Hormone MelatoninMarilena Vlachou, Stefanos Kikionis, Angeliki Siamidi, et al.
International Journal of Pharmaceutics|August 18, 2024
Sustained release of 3D printed bupropion hydrochloride tablets bearing Braille imprints for the visually impairedChrystalla Protopapa, Angeliki Siamidi, Laura Andrade Junqueira, et al.
Current Pharmaceutical Design|April 15, 2024
<i>In vitro</i> Modified Release Studies on Melatoninergic Fluorinated Phenylalkylamides: Circumventing their Lipophilicity for Oral AdministrationMarilena Vlachou, Angeliki Siamidi, Chrystalla Protopapa, et al.
Acta Pharmaceutica (Zagreb, Croatia)|May 16, 2020
Probing the release of the chronobiotic hormone melatonin from hybrid calcium alginate hydrogel beadsMarilena Vlachou, Angeliki Siamidi, Efstratia Goula, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
3D-Printed Melatonin Tablets with Braille Motifs for the Visually ImpairedChrystalla Protopapa, Angeliki Siamidi, Aikaterini Sakellaropoulou, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Biophysical Evaluation and In Vitro Controlled Release of Two Isomeric Adamantane Phenylalkylamines with Antiproliferative/Anticancer and Analgesic ActivityMarilena Vlachou, Angeliki-Sofia Foscolos, Angeliki Siamidi, et al.
Drug Research|July 21, 2017
In vitro Controlled Release of two new Tuberculocidal Adamantane Aminoethers from Solid Pharmaceutical Formulations (II)Marilena Vlachou, Angeliki Siamidi, Dimitrios Spaneas, et al.
Pageof 4